PALX Palomino Laboratories Inc.
Semiconductors & Related Devices · OTC · SEC CIK 1938569 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-219.5%
TTM EPS YoY108.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-60.1%
ROA-55.5%
ROIC (approx.)-7,675.4%
Asset turnover—
Leverage & solvency
Liabilities / assets5.9%
Debt / equity0.00x
Current ratio18.90x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.61x
Accruals ratio-21.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 |
|---|---|---|---|
| Income statement | |||
| Revenue | — | — | — |
| SG&A expense | $2.70M | $6,123 | $83,937 |
| Operating income | -$2.70M | -$6,123 | -$83,937 |
| Interest expense | — | $5,786 | — |
| Net income | -$3.16M | -$16,198 | -$83,937 |
| EPS (basic) | -0.47 | -0.01 | -0.02 |
| EPS (diluted) | -0.47 | -0.01 | -0.02 |
| Weighted avg. shares (diluted) | 6.71M | 1.52M | 5.00M |
| Balance sheet | |||
| Cash & equivalents | $8.12M | $135,000 | $139,527 |
| Current assets | $8.43M | $138,125 | $380 |
| Total assets | $8.43M | $138,125 | $380 |
| Current liabilities | $337,000 | $6,431 | $111,621 |
| Total liabilities | $337,000 | $156,431 | $111,621 |
| Shareholders' equity | $8.10M | -$17,000 | -$17,000 |
| Shares outstanding | 18.77M | 4.50M | 5.00M |
| Cash flow statement | |||
| Operating cash flow | -$1.28M | -$4,870 | -$79,379 |
| Financing cash flow | $9.27M | $195,437 | $79,259 |
| Stock-based compensation | $1.44M | — | — |
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.